*From the Authors*:

We thank Professors Nalos and Robergs for their supportive comments concerning our paper and our hypotheses ([@bib1]), particularly with regard to the lack of a direct causal relationship between elevated lactate and acidemia in patients with sepsis. Moreover, we agree that the cause of hyperlactatemia is often multifactorial and that the use of catecholamines is certainly a well-accepted contributor. In our population, lactate and epinephrine were weakly but significantly related (*R*^2^ = 0.06; *P* \< 0.0001). Professors De Backer and Vincent disagree with us on several points, which deserve a point-by-point reply.1.They stated that "hyperlactatemia can be of hypoxic origin even in the absence of acidosis, and of nonhypoxic origin even when there is acidemia." The confusion here might stem from confounding of the terms "acidosis" and "acidemia." As soon as it is released into the blood, lactate (a strong negative ion) causes acidemia. If the measured pH does not fall, it simply means that other cofactors are operating. In our 1,741 patients with sepsis, the primary cofactor that determined acidemia was kidney function. Therefore, the relationship between acidemia and lactate has nothing to do with lactate origin.2.They stated that "high Sv~O~2~~ values can be the result of microcirculatory alterations." Actually, in their own cited work, they showed that microcirculation was altered in patients with sepsis compared with patients without sepsis, but venous oxygen saturation (Sv~O~2~~) values were similar.3.They stated that elevated Scv~O~2~~ is compatible with inadequate perfusion (due to peripheral shunt), thus implying a need for further fluid resuscitation. This argument reflects the common belief that if peripheral shunt increases, the Scv~O~2~~ will increase despite inadequate oxygen delivery. The validity of this concept may be tested by considering the periphery as comprised of two compartments: one oxygen consuming ($\overset{.}{V}$[o]{.smallcaps}~2~) and perfused ($\overset{.}{\text{Q}}$− $\overset{.}{\text{Q}}$sp), and one not oxygen consuming but perfused ($\overset{.}{\text{Q}}$sp). Accordingly, the "peripheral shunt" fraction ($\overset{.}{\text{Q}}$sp/$\overset{.}{\text{Q}}$) may be described as:
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where Scv~O~2~~ and Sa~O~2~~ are the central venous and arterial oxygen saturations, respectively, and Sv~O~2~id~ is the oxygen saturation of the blood exiting the $\overset{.}{V}$[o]{.smallcaps}~2~ consuming/perfused compartment. Therefore:
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where *k* = Hb (g/L) × 1.39 ml O~2~/g Hb.

The Scv~O~2~~, which derives from the sum of Scv~O~2~id~ and Sa~O~2~~ of the shunted blood, is equal to:
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Then, substituting Sv~O~2~id~:
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from which, solving and simplifying for $\left( {1 - \frac{\overset{.}{\text{Q}}\text{sp}}{\overset{.}{\text{Q}}}} \right)$:
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Finally:
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where D[o]{.smallcaps}~2~ is the oxygen delivery (oxygen arterial content × $\overset{.}{\text{Q}}$). This relationship indicates that the Scv~O~2~~ is completely independent of peripheral shunt and depends inversely on the $\overset{.}{V}$[o]{.smallcaps}~2~/$\overset{.}{\text{Q}}$ratio. The greater the ratio, the lower the Scv~O~2~~; the lower the ratio, the higher the Scv~O~2~~. The paper by Monnet and colleagues ([@bib2]) that was cited by De Backer and Vincent fully supports our hypothesis: Scv~O~2~~ did not change in the "$\overset{.}{V}$[o]{.smallcaps}~2~ responders" to a saline challenge (as the $\overset{.}{V}$[o]{.smallcaps}~2~/$\overset{.}{\text{Q}}$ was unmodified) but did increase in the "$\overset{.}{V}$[o]{.smallcaps}~2~ nonresponders," as the $\overset{.}{V}$[o]{.smallcaps}~2~/$\overset{.}{\text{Q}}$ratio decreased due to increased $\overset{.}{\text{Q}}$. Therefore, the main determinant of a high Scv~O~2~~ is lowering of the global $\overset{.}{V}$[o]{.smallcaps}~2~/$\overset{.}{\text{Q}}$ ratio.

We acknowledge that altered metabolism (aerobic glycolysis \[the Warburg effect\] \[[@bib3]\]) or the generation of inflammatory products (e.g., O~2~ radical production) during sepsis may drive global $\overset{.}{V}$[o]{.smallcaps}~2~ and $\overset{.}{\text{Q}}$ upward, and that regional misallocation of $\overset{.}{\text{Q}}$ may compromise some organs but not others. Giving fluids, however, is not likely to fix this "inappropriate distribution/extraction" problem once hypotension has been adequately addressed by initial resuscitation. Furthermore, administering fluids in patients who show fluid responsiveness does not necessarily translate to better outcomes, and unnecessary fluid loading may cause harm, as strongly suggested by the supranormal oxygen transport approach ([@bib4], [@bib5]). We encourage readers to measure and monitor physiology to guide the most appropriate treatment.
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